Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
Paul Thompson MD
Paul D. Thompson MD Advisory Board
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
See All Experts
story of the week
Published in Cardiology and
2 other channels

Journal Scan / Review · April 04, 2014

Effect of ACE Inhibitors and ARBs on Cardiovascular Outcomes in Diabetes

JAMA Internal Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

Moshe Ornstein MD

JAMA Internal Medicine
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus: A Meta-Analysis
JAMA Intern Med 2014 Mar 31;[EPub Ahead of Print], J Cheng, W Zhang, X Zhang, F Han, X Li, X He, Q Li, J Chen

Further Reading

Most Read This Week

Recently Updated